- Home
- IMUX vs BRAG Comparison
IMUX vs BRAG Comparison
Compare IMUX & BRAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMUX
- BRAG
- Stock Information
- Founded
- IMUX 2016
- BRAG 2018
- Country
- IMUX United States
- BRAG Canada
- Employees
- IMUX N/A
- BRAG N/A
- Industry
- IMUX Biotechnology: Pharmaceutical Preparations
- BRAG Office Equipment/Supplies/Services
- Sector
- IMUX Health Care
- BRAG Technology
- Exchange
- IMUX Nasdaq
- BRAG Nasdaq
- Market Cap
- IMUX 100.0M
- BRAG 94.0M
- IPO Year
- IMUX N/A
- BRAG N/A
- Fundamental
- Price
- IMUX $0.95
- BRAG $4.17
- Analyst Decision
- IMUX Strong Buy
- BRAG Buy
- Analyst Count
- IMUX 6
- BRAG 3
- Target Price
- IMUX $12.67
- BRAG $6.67
- AVG Volume (30 Days)
- IMUX 991.0K
- BRAG 72.3K
- Earning Date
- IMUX 02-20-2025
- BRAG 11-14-2024
- Dividend Yield
- IMUX N/A
- BRAG N/A
- EPS Growth
- IMUX N/A
- BRAG N/A
- EPS
- IMUX N/A
- BRAG N/A
- Revenue
- IMUX N/A
- BRAG $109,522,641.00
- Revenue This Year
- IMUX N/A
- BRAG $11.40
- Revenue Next Year
- IMUX N/A
- BRAG $10.75
- P/E Ratio
- IMUX N/A
- BRAG N/A
- Revenue Growth
- IMUX N/A
- BRAG 4.64
- 52 Week Low
- IMUX $0.95
- BRAG $2.86
- 52 Week High
- IMUX $2.11
- BRAG $7.00
- Technical
- Relative Strength Index (RSI)
- IMUX 36.31
- BRAG 63.83
- Support Level
- IMUX $0.99
- BRAG $3.29
- Resistance Level
- IMUX $1.05
- BRAG $4.25
- Average True Range (ATR)
- IMUX 0.07
- BRAG 0.22
- MACD
- IMUX -0.00
- BRAG 0.08
- Stochastic Oscillator
- IMUX 1.50
- BRAG 91.67
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
About BRAG Bragg Gaming Group Inc.
Bragg Gaming Group Inc is predominantly a B2B online gaming technology platform and casino content aggregator. The Company's proprietary studios offer high-performing, data-driven casino gaming titles from in-house brands Wild Streak, Spin, Atomic Slot Lab, Indigo Magic and Oryx Gaming. It offers a full range of games including slot games, table games, card games, video bingo, scratch card games, virtual sports, and live dealer games which are featured on the company's PAM platform and also available for use on other gaming platforms offered by third parties. Geographically, the company generates a majority of its revenue from the Netherlands and the rest from Curacao, Malta, United States, Croatia, and other regions.